Study to Compare Feasibility of 1-step Injectable Artesunate vs. Conventional 2-step Injectable Artesunate

NCT05140278 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Severe Malaria

Interventions

DRUG: Argesun 60mg (1 step parenteral artesunate)
DRUG: Artesun 60mg (2-step parenteral artesunate)

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]
[object Object]